Shield Therapeutics plc (AIM:STX)

Shield Therapeutics Revenue

Shield Therapeutics had revenue of $30.37M USD in the half year ending June 30, 2026, with 150.34% growth. This brings the company's total for the last twelve months to $58.63M, up 41.28% year-over-year. In the year 2025, Shield Therapeutics had annual revenue of $49.70M with 54.45% growth. That makes Shield Therapeutics the 26,727th largest company in the world by revenue and 571st in the United Kingdom.

• Revenue (ttm): $58.63M
• Revenue Growth: +41.28%
• P/S Ratio: 1.36
• Revenue / Employee: $961.07K
• Employees: 61
• Market Cap: 59.92M GBP

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Geography

Chart

• United States 45.78M 92.1%
• The Netherlands 2.76M 5.5%
• Canada 831.00K 1.7%
• Japan 338.00K 0.7%

Fiscal year ended Dec 31, 2025 See the full Shield Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	49.70M	17.52M	54.45%
Dec 31, 2024	32.18M	19.10M	145.93%
Dec 31, 2023	13.09M	7.59M	137.95%
Dec 31, 2022	5.50M	3.45M	167.76%
Dec 31, 2021	2.05M	-12.15M	-85.54%
Dec 31, 2020	14.20M	13.25M	1,389.43%
Dec 31, 2019	953.46K	-14.18M	-93.70%
Dec 31, 2018	15.13M	14.27M	1,657.92%
Dec 31, 2017	860.83K	485.65K	129.44%
Dec 31, 2016	375.19K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Oct 22, 2026

Data Sources Report a data error